The American Journal of Medicine
Volume 121, Issue 9 , Pages 789-796 , September 2008

COPD as a Systemic Disease: Impact on Physical Functional Limitations

  • Mark D. Eisner, MD, MPH

      Affiliations

    • Division of Occupational and Environmental Medicine and Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Division of Research, Kaiser Permanente, Oakland, Calif
    • Corresponding Author InformationCorresponding Author: Mark D. Eisner, MD, MPH, University of California, San Francisco, 505 Parnassus Avenue, M-1097, San Francisco, CA 94143-0111, Telephone (415) 476-7351, Fax (415) 476-6426
    • ,
  • Paul D. Blanc, MD, MSPH

      Affiliations

    • Division of Occupational and Environmental Medicine and Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • ,
  • Edward H. Yelin, PhD

      Affiliations

    • Institute for Health Policy Studies, Department of Medicine, University of California, San Francisco
    • ,
  • Stephen Sidney, MD, MPH

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif
    • ,
  • Patricia P. Katz, PhD

      Affiliations

    • Institute for Health Policy Studies, Department of Medicine, University of California, San Francisco
    • ,
  • Lynn Ackerson, PhD

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif
    • ,
  • Phenius Lathon, BS

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif
    • ,
  • Irina Tolstykh, MS

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif
    • ,
  • Theodore Omachi, MD, MPH

      Affiliations

    • Division of Occupational and Environmental Medicine and Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • ,
  • Nancy Byl, PhD

      Affiliations

    • Department of Physical Therapy and Rehabilitation, University of California, San Francisco
    • ,
  • Carlos Iribarren, MD, MPH, PhD

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif

References 

  1. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome?. Lancet. 2007;370:797–799
  2. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586
  3. Jette DU, Manago D, Medved E, et al. The disablement process in patients with pulmonary disease. Phys Ther. 1997;77:385–394
  4. Williams SJ, Bury MR. ‘Breathtaking’: The consequences of chronic respiratory disorder. Int Disabil Stud. 1989;11:114–120
  5. Verbrugge LM, Jette AM. The disablement process. Soc Sci Med. 1994;38:1–14
  6. Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res. 2007;8:7
  7. Sidney S, Sorel M, Quesenberry CP, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068–2075
  8. Calfee CS, Katz PP, Yelin EH, et al. The influence of perceived control of asthma on health outcomes. Chest. 2006;130:1312–1318
  9. Eisner MD, Yelin EH, Katz PP, et al. Risk factors for work disability in severe adult asthma. Am J Med. 2006;119:884–891
  10. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary). Am J Respir Crit Care Med. 2001;163:1256–1276
  11. American Thoracic Society. Standardization of spirometry–1987 update (Statement of the American Thoracic Society). Am Rev Respir Dis. 1987;136:1285–1298
  12. Standardization of Spirometry, 1994 Update (American Thoracic Society). Am J Respir Crit Care Med. 1995;152:1107–1136
  13. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179–187
  14. Fabbri LM, Hurd SS. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J. 2003;22:1–2
  15. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919–923
  16. Sciurba F, Criner GJ, Lee SM, et al. Six-minute walk distance in chronic obstructive pulmonary disease: Reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med. 2003;167:1522–1527
  17. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
  18. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–561
  19. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: Consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55:M221–M231
  20. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–M94
  21. Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45:M192–M197
  22. Duncan PW, Studenski S, Chandler J, et al. Functional reach: predictive validity in a sample of elderly male veterans. J Gerontol. 1992;47:M93–M98
  23. Weiner DK, Duncan PW, Chandler J, Studenski SA. Functional reach: a marker of physical frailty. J Am Geriatr Soc. 1992;40:203–207
  24. Weiner DK, Bongiorni DR, Studenski SA, et al. Does functional reach improve with rehabilitation?. Arch Phys Med Rehabil. 1993;74:796–800
  25. Kendall FP, McReary EK, Provance PG. Muscles (Testing and Function). Fourth ed.. Baltimore: Williams & Wilkins; 1993;
  26. Adams LS, Greene LW, Topoozian E. American Association of Hand Therapists Clinical Assessment Recommendations. Vol 7 New York: Churchill Livingstone; 1999;
  27. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg [Am]. 1984;9:222–226
  28. Sternfeld B, Ngo L, Satariano WA, Tager IB. Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am J Epidemiol. 2002;156:110–121
  29. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  30. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Pub Health. 1998;88:15–19
  31. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007;370:741–750
  32. Eisner MD, Wang Y, Haight TJ, et al. Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. Ann Epidemiol. 2007;17:364–373
  33. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: Data from the Third National Health and Nutrition Examination. J Intern Med. 2003;254:540–547
  34. Skeletal muscle dysfunction in chronic obstructive pulmonary disease (A statement of the American Thoracic Society and European Respiratory Society). Am J Respir Crit Care Med. 1999;159:S1–S40
  35. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152:2021–2031
  36. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:629–634
  37. Gosker HR, Lencer NH, Franssen FM, et al. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest. 2003;123:1416–1424
  38. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153:976–980
  39. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994;150:11–16
  40. Gosselink R, Decramer M. Peripheral skeletal muscles and exercise performance in patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 1998;53:419–423
  41. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;71:733–738
  42. Rantanen T, Masaki K, Foley D, et al. Grip strength changes over 27 years in Japanese-American men. J Appl Physiol. 1998;85:2047–2053
  43. Fink G, Moshe S, Goshen J, et al. Functional evaluation in patients with chronic obstructive pulmonary disease: Pulmonary function test versus cardiopulmonary exercise test. J Occup Environ Med. 2002;44:54–58
  44. McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J. 1976;1:822–823
  45. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978;2:241–243
  46. Poulain M, Durand F, Palomba B, et al. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003;123:1401–1407
  47. Eisner MD, Balmes J, Katz PP, et al. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4:7
  48. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance–United States, 1971-2000. MMWR Surveill Summ. 2002;51:1–16
  49. Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–2527
  50. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Pub Health. 1992;82:703–710

 Funded by: NHLBI/NIH R01HL077618.

PII: S0002-9343(08)00490-7

doi: 10.1016/j.amjmed.2008.04.030

The American Journal of Medicine
Volume 121, Issue 9 , Pages 789-796 , September 2008

Article Tools